SCHEMBL1827282

SCHEMBL1827282

CC(=O)OC(C#N)c1ccc(OS(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.46
ADAMTS4 O75173 1/20 0.46
MAPT P10636 5/20 0.43
ALDH1A1 P00352 3/20 0.43
ENPP3 O14638 6/20 0.43
ENPP1 P22413 6/20 0.43
ENPP2 Q13822 4/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
ALPL P05186 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
MAOB P27338 1/20 0.38
RECQL P46063 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1822254 0.89 KMT2A (0.46) MAPTALDH1A1ENPP3ENPP1ENPP2
SCHEMBL1823219 0.86 ALDH1A1 (0.44) TDP1ADAMTS4MAPTALDH1A1MEN1
SCHEMBL1825498 0.84 TDP1 (0.50) TDP1ADAMTS4MAPTALDH1A1ENPP3
SCHEMBL1826065 0.82 ENPP3 (0.38) MAPTALDH1A1ENPP3ENPP1SMN1; SMN2
SCHEMBL1823927 0.82 MAPT (0.42) ADAMTS4MAPTALDH1A1MEN1KMT2A
SCHEMBL1827216 0.81 TDP1 (0.50) TDP1ADAMTS4MAPTALDH1A1ENPP3
SCHEMBL1821274 0.81 TDP1 (0.47) TDP1ADAMTS4MAPTALDH1A1ENPP3
SCHEMBL2835326 0.80 ALDH1A1 (0.50) TDP1MAPTALDH1A1MEN1KMT2A
SCHEMBL7699172 0.80 ALDH1A1 (0.50) TDP1MAPTALDH1A1MEN1KMT2A
SCHEMBL1826916 0.80 TDP1 (0.49) TDP1ADAMTS4MAPTALDH1A1ENPP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 TDP1 4543/4885ADAMTS4 4799/4885MAPT 4712/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 TDP1 4702/4885ADAMTS4 4532/4885MAPT 2237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.